Gordon Milne
Partner
London
Gordon Milne
Partner
London
Contact Details
Gordon is a private equity partner based in London. He advises private equity houses, financial sponsors and their portfolio companies on the full range of cross border M&A and corporate finance transactions including complex carve-outs and public-to-private takeovers. He has over 20 years of private equity experience.
He is recognised as a Leading Individual by Chambers and Legal 500.
Qualifications
Professional
Admitted as solicitor, Scotland, 1999
Admitted as solicitor, England and Wales, 2002
Academic
Diploma, Law, University of Strathclyde, 1996
LLB, Law, University of Strathclyde, 1996
Related articles
News: 27 April 2023
Allen & Overy advises Exponent on sale of Enva to I Squared Capital
Allen & Overy has advised Exponent on the sale of Enva, a leading provider of recycling and resource recovery solutions, to I Squared Capital, an independent global infrastructure manager.
News: 09 March 2023
Allen & Overy advises Charterhouse on the divestment of Tarsus to Informa PLC
Experience highlights
Advising ERM, the world’s largest pureplay sustainability consultancy, and its majority shareholders, OMERS Private Equity and AIMCo on the sale of ERM to KKR.
Advising Exponent Private Equity on the sale of the BBI Group to Novo Holdings, a world-leading life science investor; and on the sale of BBI Healthcare to Venture Life Group, a leader in developing, manufacturing and commercialising products for the international self-care market.
Advising PAI Partners on the simultaneous acquisitions of Addo Food Group (Addo) and Winterbotham Darby from LDC and Equistone (respectively) and existing management.
Advising Charterhouse, through its wholly owned subsidiary Tiger Acquisitions UK, on its cash bid for Tarsus Group.
Qualifications
Professional
Admitted as solicitor, Scotland, 1999
Admitted as solicitor, England and Wales, 2002
Academic
Diploma, Law, University of Strathclyde, 1996
LLB, Law, University of Strathclyde, 1996
Other noteworthy experience
- Exponent Private Equity and its portfolio company, Moonpig, on the demerger of Moonpig from another Exponent portfolio company, Photobox Group, the refinancing of each of Moonpig and Photobox and the subsequent IPO of Moonpig.
- Bridgepoint on its acquisition of Fishawack, an independent global healthcare communication group from Lloyds Development Capital.
- Exponent on the merger of Photobox and Albelli.
- The Consortium on the sale of New Scientist Group Limited, the renowned weekly science and technology magazine, to the Daily Mail and General Trust.
- Charterhouse Capital Partners on its public to private acquisition of Tarsus Group plc, an operator of business-to-business exhibitions.
- Exponent Private Equity on its acquisition of the TRS Group, a family owned supplier of wholesale ethnic foods from TRS Group (UK) Limited.
- Advent International on the sale of allnex Group to Netherlands-based PTTGC International (Netherlands) B.V., a wholly owned subsidiary of Bangkok-based PTT Global Chemical Public Company Limited (“PTTGC”).
- Exponent Private Equity on the sale of the Loch Lomond Distillers Group to Hillhouse Capital Management.
- Exponent on the sale of Fintrax, one of the world's biggest providers of tax free shopping and dynamic currency conversion, to French private equity firm Eurazeo.
Recognition
He is incredibly experienced and very pragmatic and commercial." "He's very smart and thoughtful in his approach.
Chambers UK, 2022
Gordon Milne is a ‘very responsive, thorough and commercial practitioner. He deploys deep transactional experience on behalf of sponsors and their portfolio companies in domestic and international buyouts and exit deals.
Chambers UK, 2020
